With multiple clinical trials and approval applications in train, nuclear medicine superstar Telix Pharmaceuticals (ASX:TLX) is like one of those irritatingly brilliant all-round students.We’re thinking of the straight-A school captain who stars in the school play, whilst padding up for the First XI in between clarinet lessons.
https://**promotion blocked**/health/dr-borehams-crucible-telix-has-homework-but-remains-dux-of-radioimaging-class/
With multiple clinical trials and approval applications in...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$13.77 |
Change
-0.380(2.69%) |
Mkt cap ! $4.659B | |||
| Open | High | Low | Value | Volume |
| $14.26 | $14.28 | $13.72 | $51.43M | 3.694M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 75 | $13.77 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.80 | 16600 | 2 |
View Market Depth
| Last trade - 16.10pm 04/09/2025 (20 minute delay) ? |
| TLX (ASX) Chart |